文献速递慢阻肺哮喘

哮喘-慢阻肺重叠的识别与定义:CanCOLD研究

Identification and definition of asthma-COPD overlap: The CanCOLD study.
PubMed 文献 · Respirology · 2020-02-16

基于CanCOLD前瞻性多中心队列中522例COPD患者,采用文献中七种常用ACO定义分析其患病率与临床特征。ACO患病率随定义不同波动于3.8%至31%,无论何种定义ACO患者肺功能、症状、急性加重及生活质量均差于单纯COPD。含特应性或医生诊断哮喘的定义区分度更好,而基于支气管舒张可逆性的定义稳定性差。

要点

  • ACO患病率因定义不同波动于3.8%至31%
  • ACO患者肺功能、症状、急性加重及生活质量均差于单纯COPD
  • 含特应性或医生诊断哮喘的定义更能区分ACO

核心结论

  • 特应性和医生诊断哮喘是识别ACO更具区分度的特征,需用气道炎症指标和生物标志物进一步验证。

研究设计与样本

  • 前瞻性多中心CanCOLD队列中纳入522例COPD患者,采用文献中七种常用ACO定义进行分析。
  • 其中264例符合至少一种ACO定义。

主要发现

  • ACO患病率随定义不同波动于3.8%至31%。
  • 无论何种定义,ACO患者肺功能更差、快速下降者比例更高、症状和急性加重更多、健康相关生活质量更差、合并症更多。
  • 非ACO患者肺气肿和细支气管炎评分更高。
  • 含特应性和/或医生诊断哮喘的三种定义识别的患者与单纯COPD显著不同。
  • 基于支气管舒张可逆性的两种定义与COPD一致且稳定性最差,每组不足50%患者随访间维持可逆性。

临床怎么用

  • 临床识别ACO时应重视特应性和医生诊断哮喘病史,而非仅依赖支气管舒张可逆性。

局限性

  • ACO定义缺乏共识,七种定义间异质性大,结果需气道炎症指标和特异性生物标志物验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Lack of consensus on diagnosis of ACO limits our understanding of the impact, management and outcomes of ACO. The present observational study aims to describe the prevalence, clinical characteristics and course of individuals with ACO based on various definitions used in clinical practice. METHODS: We included individuals with COPD from the prospective, multisite CanCOLD study and defined subjects with ACO using seven definitions commonly used in the literature. RESULTS: Data including questionnaires, lung function and CT scans were analysed from 522 individuals with COPD who were randomly recruited from the population. Among them, 264 fulfilled at least one of the seven definitions of ACO. Prevalence of ACO varied from 3.8% to 31%. Regardless of the definition, individuals with ACO had worse outcomes (lung function and higher percentage of fast decliners, symptoms and exacerbations, health-related quality of life and comorbidities) than the remaining patients with COPD. Conversely, patients with non-ACO had higher emphysema and bronchiolitis scores. The three definitions that included atopy and/or physician diagnosis of asthma identified subjects who differed significantly from patients with COPD. The two ACO definitions with post-bronchodilator reversibility were concordant with COPD and were the least stable, with less than 50% of the patients from each group maintaining reversibility over visits. CONCLUSION: Atopy and physician-diagnosed asthma are more distinguishing characteristics to identify ACO. This finding needs to be validated using measures of airway inflammation and other specific biomarkers.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Barrecheguren M, Pinto L, Mostafavi-Pour-Manshadi SM, et al. Identification and definition of asthma-COPD overlap: The CanCOLD study. Respirology. 2020. PMID: 32064708. doi:10.1111/resp.13780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。